Cellectis - bioresearch

Cellectis bioresearch announces the launch of its first cGPS® kit for use in gene function studies

 

Paris, December 7, 2009 - Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis S.A. (Alternext : ALCLS), today announced the launch of cGPS^® NIH-3T3, its fist research kit that can be used to modify the NIH-3T3 cell line to study gene functions.

 The NIH-3T3 cell line is commonly used in academic research laboratories as it is a good model for studying human gene functions as well. The new cGPS^® kit developed by Cellectis bioresearch will allow scientists to perform targeted integration of a gene in NIH-3T3 cells, a key step in the understanding of its function.

 « This is the fifth product launched by Cellectis bioresearch this year and the first to address gene function studies, which is a huge market given the number of academic scientists that could have use of such a kit » said Luc Selig, VP Sales & Marketing for Cellectis bioresearch. « It is part of a portfolio that includes products for drug discovery and protein production in addition to those for the gene function studies. We plan to roll-out a large line of new products to all three priority markets during 2010 ».

 Cellectis bioresearch currently supplies two targeted integration product lines - cGPS^® (cellular Genome Positioning System) and cGPS^® Custom - both of which can be purchased via www.cellectis-bioresearch.com. 

---